Late diagnosis of HIV infection in Brazil despite over 15 years of free and universal access to treatment

AIDS Research and Human Retroviruses

Volumn 28, Issue 12, 2012, Pages 1541-1542

  Schechter, Mauro ^a   Pacheco, Antonio G ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; DELAYED DIAGNOSIS; DISEASE SURVEILLANCE; FEMALE; HEALTH CARE ACCESS; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORTALITY; PRIORITY JOURNAL; VOLUNTARY COUNSELING AND TESTING;

ADULT; AGED; BRAZIL; CD4 LYMPHOCYTE COUNT; DELAYED DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84870002344     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0077     Document Type: Letter

References (8)

1. Sabin CA, Schwenk A, Johnson MA, et al.: Late diagnosis in the HAART era: Proposed common definitions and associations with mortality. AIDS 2010;24(5):723-727.
2. Rodger A, Lodwick R, Schechter M, et al.: Mortality in Patients with Well-controlled HIV and High CD4 Counts in the cART Arms of the SMART and ESPRIT Randomized Clinical Trials Compared to the General Population. Abstract 638, 19th Conference on Retroviruses and Opportunistic Infections, 2012.
3. Nash D, Katyal M, Brinkhof MWG, et al.: Long-term immu-nologic response to antiretroviral therapy in low income countries: A collaborative analysis of prospective studies. AIDS 2008;22:2291-2302.
4. Cohen MS, Chen YQ, McCauley M, et al.: Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
5. Buchacz K, Armon C, Palella FJ, et al.: CD4 cell counts at HIV diagnosis among HIV outpatient study participants, 2000-2009. AIDS Res Treat 2012:869841.
6. Borghi V, Girardi E, Bellelli S, et al.: Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr 2008;49(3):282-286.
7. Lanoy E, Mary-Krause M, Tattevin P, et al.: Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007;12(1):89-96.
8. Sá MS, Sampaio J, Haguihara T, et al.: Clinical and laboratory profile of HIV-positive patients at the moment of diagnosis in Bahia, Brazil. Braz J Infect Dis 2007;11(4):395-398.